Fortrea Holdings, Inc. (FTRE)
20.19
+0.13
(+0.65%)
USD |
NASDAQ |
Nov 13, 16:00
20.19
0.00 (0.00%)
After-Hours: 19:59
Fortrea Holdings EPS Diluted (Quarterly) : 0.0059 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0059 |
| June 30, 2026 | -0.1392 |
| March 31, 2026 | -0.2521 |
| December 31, 2025 | -0.3502 |
| September 30, 2025 | -0.1743 |
| June 30, 2025 | -4.138 |
| March 31, 2025 | -6.248 |
| December 31, 2024 | -0.7224 |
| September 30, 2024 | -0.3114 |
| June 30, 2024 | -1.289 |
| Date | Value |
|---|---|
| March 31, 2024 | -1.132 |
| December 31, 2023 | -0.6137 |
| September 30, 2023 | -0.1577 |
| June 30, 2023 | 0.3468 |
| March 31, 2023 | 0.1411 |
| December 31, 2022 | 0.377 |
| September 30, 2022 | 0.6824 |
| June 30, 2022 | 0.7478 |
| March 31, 2022 | 0.3668 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Charles River Laboratories International, Inc. | 6.856 |
| IQVIA Holdings, Inc. | 2.096 |
| Medpace Holdings, Inc. | 4.845 |
| Champions Oncology, Inc. | -0.0306 |
| Avantor, Inc. | 0.2987 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.60M |
| Revenue (Quarterly) | 691.50M |
| Total Expenses (Quarterly) | 690.90M |
| Enterprise Value | 2.834B |
| Gross Profit Margin (Quarterly) | 17.28% |
| Profit Margin (Quarterly) | 0.09% |
| Earnings Yield | -3.64% |
| Operating Earnings Yield | 2.35% |
| Normalized Earnings Yield | -2.382 |